Background-The effect of moderate left ventricular systolic dysfunction (LVSD) on ventricular/vascular coupling and the aortic pressure waveform (AoPW) has been well described, but the effect of severe LVSD has not. Methods and Results-We used noninvasive, high-fidelity tonometry of the radial artery and a mathematical transfer function to generate the AoPW in 25 treated patients with LVSD (mean LV ejection fraction, 24Ϯ8.8%; range, 11% to 40%; 21 patients Ͻ30%). Pulse wave analysis of the AoPW was used to characterize ventricular/vascular coupling and compared with pulse wave analysis performed in 25 normal subjects matched for age, gender, height, body mass index, and heart rate. Measurements obtained using pulse wave analysis in LVSD patients indicated features of poor LV stroke performance and also reduced indices of arterial stiffness: increased travel time of the pressure wave (147Ϯ10 ms versus 132Ϯ21 ms; PϽ0.001); decreased systolic duration of reflected wave (134Ϯ24 ms versus 167Ϯ26 ms; PϽ0.001); ejection duration (277Ϯ22 ms versus 299Ϯ25 ms; PϽ0.008); percent systolic duration (32Ϯ5.3% versus 35Ϯ4.0%; PϽ0.02); aortic systolic pressure (100Ϯ16 mm Hg versus 121Ϯ16 mm Hg; PϽ0.001); unaugmented pressure (24Ϯ6.3 mm Hg versus 32Ϯ6.4 mm Hg; PϽ0.001); augmented pressure (4.8Ϯ3.1 mm Hg versus 9.6Ϯ4.5 mm Hg; PϽ0.001); pulse pressure (28Ϯ7.4 mm Hg versus 42Ϯ9.5 mm Hg; PϽ0.001); augmentation index (12Ϯ6.6% versus 23Ϯ7.6%; PϽ0.006); wasted LV effort (5.3Ϯ2.8ϫ10 2 dyne sec/cm 2 versus 17Ϯ10ϫ10 2 dyne sec/cm 2 ; PϽ0.001); systolic pressure time index (17Ϯ4.1ϫ10 2 mm Hg-sec/min versus 23Ϯ4.2ϫ10 2 mm Hg sec/min; PϽ0.001); and pressure systolic area (383Ϯ121 mm Hg sec/min versus 666Ϯ150 mm Hg sec/min; PϽ0.001). Conclusions-Severe LVSD causes measurable changes in the AoPW. Standardization of AoPW findings in LVSD patients may allow for the clinical use of radial artery pulse wave analysis to noninvasively determine the severity of dysfunction and aid in logical therapy. (Circ Heart Fail. 2010;3:149-156.) 
T he measured central aortic pressure waveform (AoPW) is the summation of a forward-traveling (incident) wave generated by left ventricular (LV) ejection and a backwardtraveling wave caused by reflection of the forward wave from sites of change in impedance within the peripheral arterial system. [1] [2] [3] Both the forward and reflected pressure waves are related to LV ejection wave amplitude. Additionally, the forward traveling wave is affected by central (elastic) arterial stiffness and peak LV ejection, whereas the reflected wave is affected by the elastic properties of the entire arterial tree, transmission velocity of the forward and reflected waves, and distance to the major reflecting site. The functions of the LV and peripheral arterial system are interactive (ie, ventricular/ vascular coupling) and conditions that directly affect one can cause a responsive change in the other. 4 The net effect of this coupling on the morphology of the AoPW can be described by a series of quantifiable characteristics obtained using pulse wave analysis (PWA). [5] [6] [7] Certain clinical conditions, such as advanced age, obesity, hypertension, diabetes mellitus, coronary artery disease, myocardial infarction, and chronic renal disease unfavorably alter ventricular/vascular coupling, and the associated changes in the AoPW have been described. 8 -12 Additionally, this unfavorable alteration of ventricular/vascular coupling is associated with increased arterial stiffness and has been linked directly to the subsequent development of adverse cardiovascular outcomes including chronic heart failure and death.
Clinical Perspective on p 156
Central aortic pulse pressure (cPP)-the difference between the central aortic systolic and diastolic blood pressure-is a characteristic of the AoPW that is relatively simple to measure. Recent studies have shown that both invasive 13 and noninvasive 14, 15 measurements of cPP correlate positively and strongly with the subsequent development of cardiovascular disease and adverse outcomes. Conversely, 3 previous large clinical studies found an inverse (or negative) relation between peripheral brachial pulse pressure (bPP) and mortality in patients with severe LV systolic dysfunction (LVSD). 16 -18 Additionally, the effects of mild to moderate LVSD on arterial stiffness and the AoPW in patients with normal mean arterial pressure have been fairly well described and show an increase in aortic stiffness, pulse wave velocity (PWV), characteristic impedance, and cPP compared with normal subjects. 19 -23 However, a quantitative description of the AoPW in patients with severe LVSD beyond cPP has not been fully described. We therefore sought to investigate changes in the AoPW associated with altered ventricular/ vascular coupling in patients with severe LVSD using noninvasive, high-fidelity tonometry of the radial artery and synthesized central aortic PWA.
Methods

LVSD Patient and Normal Subject Populations
This cross sectional study was approved by the University of Florida Institutional Review Board, and all LVSD patients (Nϭ25) and normal subjects gave informed written consent. Twenty-three of the LVSD patients had New York Heart Association Class III to IV chronic congestive heart failure symptoms. Additionally, all LVSD patients were in normal sinus rhythm; all had undergone quantitative echocardiography which confirmed LVSD as the cause of heart failure (LV ejection fraction [EF] range, 11% to 40%; 21 patients Ͻ30%) and demonstrated no significant valvular abnormality, and all were receiving medical therapy accordingly. Data from these 25 LVSD patients were compared with those from a group of normal subjects (Nϭ25) matched for age, gender, height, body mass index, and heart rate. Normal subjects were all asymptomatic, had no history of cardiovascular disease, and had normal clinical examinations and normal ECGs. None of them were current smokers or taking cardiovascular drugs at the time of the study. All patients and subjects had data collected in the basal state, in the supine position, and in a quiet, temperature-controlled room after a rest period of at least 10 minutes.
Peripheral Cuff Blood Pressure Measurement
Brachial systolic and diastolic blood pressures (bSP and bDP, respectively) were measured in the left arm using a validated, automatic, oscillometric BP monitor (Omron R3, Omron Healthcare, Kyoto, Japan), and an appropriately sized cuff. Three measurements were taken at least 2 minutes apart and the latter 2 were averaged and used in data analysis and calibration of the AoPW. The variable bPP was calculated as the difference between bSP and bDP.
Pulse Waveform Analysis
Assessment of wave reflection characteristics, ejection duration, and area indices were performed using the SphygmoCor system (AtCor Medical, Sydney, Australia). Radial artery pressure waveforms, calibrated using cuff measured brachial systolic and diastolic pressure, were recorded at the left wrist noninvasively, using applanation tonometry that incorporated a high-fidelity micromanometer (Millar Instruments, Houston, Tex). A validated generalized mathematical transfer function was applied to 20 sequential waveforms, which were then ensemble averaged to generate the central AoPW ( Figure 1 ). 24 Characteristics of the AoPW were then determined using PWA. 5, 6, 25 Importantly, the time from the beginning upstroke of the synthesized aortic systolic pressure waveform (P d ) to the upstroke of the reflected wave (inflection point, P i ) is the round-trip travel time (Tr) of the pressure wave to and from the major reflecting site in the lower body and is related to arterial stiffness of the entire arterial system. 2, 4, 7 Increased arterial stiffness increases PWV and leads to a more rapid Figure 1 . A synthesized central aortic pressure waveform. The early part of the ascending aortic pressure wave of amplitude (P i ϪP d ) is generated by LV ejection. The later part of the pressure wave with amplitude (P s ϪP i ) is generated by the reflected wave arriving during systole and adding to the forward pressure wave. cPPϭ(P i ϪP d )ϩ(P s ϪP i )ϭ(P s ϪP d ) and AI a ϭ(P s ϪP i )/(P s ϪP d ).
The area under the systolic portion of the reflected wave (dark shaded area) is defined as LV wasted effort (E w ). PSAϭ⌬PSAϩE w and is the area enclosed by the systolic pulse pressure wave. SPTIϭ⌬SPTIϩ⌬PSAϩE w and is the area under the systolic portion of the pressure wave and DPTI is the area under the diastolic portion of the wave. P1 indicates the first systolic pressure peak (or shoulder); P i , merging point (inflection point) of the forward and reflected waves; Tr, round-trip travel time of the pressure wave; SDR, systolic duration of reflected wave; ED, ejection duration. Data are presented as meanϮSD or n (%). NYHA indicates New York Heart Association; NA, not available; CAD, coronary artery disease; CABG, coronary artery bypass grafting; ICD, intracardiac defibrillator; ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotension receptor blocker; ALD, aldosterone.
return of the reflected wave from the periphery to the heart, a shorter Tr, and a longer systolic duration of the reflected wave (SDR). 4, 7 Aortic augmentation index (AI a ), a measure of wave reflection intensity, can be estimated as the ratio of wave reflection amplitude (P s ϪP i ) and cPP (P s ϪP d ). When the reflected wave returns during systole as a result of increased PWV and/or decreased reflection site distance, as seen in Figure 1 , the aortic pressure is augmented in late systole, and, therefore, the LV must generate enough effort to overcome this augmentation in pressure and opposition to emptying during flow deceleration. 4 This pressure effort, which takes into account both amplitude and SDR, is wasted (ie, wasted effort, E w ) because it does not contribute to blood flow production and can be estimated as the area under the systolic portion of the reflected wave. 26 E w is that portion of the systolic pressure time index (SPTI) resulting from wave reflection and is directly related to LV hypertrophy. 26 The SPTI is directly related to myocardial oxygen demand and is estimated as the area under the systolic portion of the aortic pressure wave above zero. 27 The pressure systolic area (PSA) is the area under the systolic portion of the aortic pressure wave above diastolic pressure. When E w is small or zero, PSA is directly related to stroke volume and is dependent on ejection duration and cPP. Diastolic pressure time index (DPTI) is an estimate of coronary artery perfusion pressure and is related to coronary blood flow and is estimated as the area under the diastolic portion of the pressure wave. The ratio of DPTI/SPTI represents the ratio of myocardial supply and demand and is termed the myocardial viability ratio. 28 The ratio of bPP and cPP is the pressure pulse amplification, and it increases as arterial stiffness and wave reflection amplitude decrease and vice versa. 4 Only high-quality recordings, defined as an in-device quality index of Ͼ80% (derived from an algorithm including average pulse height, pulse height variation, diastolic variation, and the maximum rate of rise of the peripheral waveform) and acceptable curves on visual inspection, were included in the analysis.
Statistical Analysis
Data for continuous variables are presented as meanϮSD. Comparisons between individual hemodynamic variables obtained from the 2 matched groups were made using a paired 2-tailed Student t test. Comparisons within the LVSD patients were made using an unpaired 2-tailed Student t test. Statistical significance was assumed when probability values were Ͻ0.05.
Figure 2.
Illustration showing the alterations in noninvasively measured radial artery and synthesized aortic pressure waves in a patient with heart failure and severe LVSD (lower panel) compared to a normal subject (upper panel) with similar heart rate, height and age. Ejection duration (270 versus 322 ms), percent systolic duration (31 versus 36%), unaugmented pressure (21 versus 29 mm Hg), augmented pressure (1.0 versus 13 mm Hg), and AI a are reduced in the heart failure patient resulting in diminished wasted LV effort (96 versus 1887 dyne sec/cm 2 ), SPTI (1880 versus 2355 mm Hg sec/min) and PSA (301 versus 627 mm Hg sec/min). In this example, mean arterial pressure was similar between the two (96 versus 98 mm Hg) while both peripheral (36 versus 50 mm Hg) and central (22 versus 41 mm Hg) pulse pressures were less in the heart failure patient. P i is the inflection point and denotes the beginning upstroke of the reflected wave. The radial artery pressure wave of the heart failure patient displays a dicrotic wave while the aortic pressure wave does not.
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Results
Patients and Subjects
The LVSD patients and normal subjects were well matched with regard to age, gender, height, body mass index, and heart rate ( Table 1 ). The mean EF for the 25 LVSD patients was 24Ϯ8.8% (range, 11% to 40%; 21 patients Ͻ30% and 4 patients Ն30%). Additionally, the LVSD patients had multiple risk conditions, and they were on multiple medications oriented toward the management of severe LVSD.
Components of Peripheral Brachial and Central Aortic Blood Pressure
All measured and calculated variables for the normal subjects were similar to those previously published for other normal subjects. 29 An example of the radial artery pressure wave and the synthesized central AoPW obtained in a normal subject and a LVSD patient is shown in Figure 2 . The measured bSP and bDP were each significantly less in LVSD patients compared with normal subjects (Table 2) , as was the calculated bPP. Additionally, the measured central systolic blood pressure, central mean pressure, cPP, and calculated unaugmented pressure (ie, forward wave amplitude [P i ϪP d ]) were each less in LVSD patients. Also, ejection duration ( Figure  3) , percent systolic duration, and PSA were each less in the LVSD patients. However, pulse pressure amplification was greater in the LVSD patients compared with normal subjects.
Amplitude and Timing of Wave Reflection Indices
The amplitude (augmented pressure) and systolic duration (SDR) of the reflected pressure wave were both less in the LVSD patients compared with the normal subjects (Table 2; Figure 3 ). Additionally, Tr of the pressure wave to and from the periphery was greater. This delay in return of the reflected wave to the heart indicates a decrease in PWV and/or an increase in reflection site distance. These differences in wave reflection characteristics produced a lower AI a and suggest a decrease in wave reflection intensity and arterial stiffness in the LVSD patients. This contention is also supported by the increase in pulse pressure amplification.
Indices of Myocardial Oxygen Demand
The observed differences in arterial wall properties and wave reflection characteristics indicate a significant reduction in pulsatile LV afterload. These afterload changes were associated with a decrease in indices of myocardial oxygen demand. The decrease in wave reflection amplitude and duration in the LVSD patients caused a decrease in E w (Table 2; Figure 3) . Also, the decreased central systolic blood pressure and abbreviated ejection duration in LVSD patients caused a decrease in the cross product (heart rateϫcentral systolic blood pressure) and estimated SPTI compared with the normal subjects. Finally, DPTI was decreased in the LVSD patients. These area changes in systole and diastole caused an increase in the myocardial viability ratio.
Intragroup Comparison of LVSD Patients Based on LVEF
Among the LVSD patients, those with LVEF Յ20% (Nϭ11) compared with those with LVEF Ͼ20% (Nϭ14) primarily contributed to the decrease in percent systolic duration (29Ϯ 4.6% versus 34Ϯ5.6%; PϽ0.04), PSA (348Ϯ86 mm Hg sec/ min versus 429Ϯ126 mm Hg sec/min; PϽ0.02), and SPTI (1484Ϯ232 mm Hg sec/min versus 1924Ϯ428 mm Hg sec/ min; PϽ0.01). Otherwise, the data from these 2 subgroups appeared similar.
Discussion
The results of this study indicate that PWA of the AoPW, determined using noninvasive, high-fidelity tonometry of the radial artery, can describe the effects of severe LVSD and altered arterial properties on ventricular/vascular coupling in the time domain. In this description, there was a decrease in all components of both central and peripheral blood pressure b indicates brachial; c, central; SP, systolic pressure; DP, diastolic pressure; PP, pulse pressure; MP, mean pressure; unaugmented pressure, (P i ϪP d ); augmented pressure, (P s ϪP i ); SDR, systolic duration of reflected wave; Tr, round-trip travel time of the pressure wave; AI a , augmentation index; E w , wasted effort; HR, heart rate; SPTI, systolic pressure time index; DPTI, diastolic pressure time index; DPTI/SPTI, myocardial viability ratio.
(systolic, diastolic, pulse, and mean) compared with normal subjects. Similar observations for peripheral blood pressure have been made in this population by others, and a low bPP has been found to be independently associated with increased mortality. 16 -18 Earlier studies, including the Systolic Hypertension in the Elderly (SHEP) and Survival and Ventricular Enlargement (SAVE) studies, found that increased conduit artery stiffness, as assessed by bPP, may contribute to increased adverse outcomes in patients with LV dysfunction. 30 -32 These studies, however, only measured the extremes in brachial blood pressure (ie, bPPϭbSPϪbDP), whereas in our study, the central AoPW, a more accurate indicator of LV afterload and adverse outcome, was measured. Several other studies have measured central AoPW, but most of those studies were performed in patients with mild-to-moderate LVSD (LVEF 30% to Ͼ40%), 20, 22, 23, [33] [34] [35] whereas our study was performed primarily in patients with severe LVSD (21 of 25). Most of the earlier studies found no change in aortic PWV and travel time of the pressure wave to and from the periphery. However, in contrast to those results, we found an increase in Tr of the pressure wave, indicating a decrease in PWV, and an increase in pulse pressure amplification, which together imply a decrease in arterial stiffness and is consistent with the measured decrease in augmented pressure and AI a . Our results are supported by the results of Tartière et al, 33 which involved patients with a similar EF (mean LVEF 24Ϯ9% among study patients with reduced EF) and which showed a decrease in the effects of wave reflection on AoPW. These pressure changes result from altered ventricular/vascular coupling. In systolic heart failure, when ventricular contractility is severely impaired, wave reflection does not boost late systolic pressure because the LV is incapable of responding adequately, so that systole is terminated prematurely, and wave reflection has a negative influence on the flow wave during deceleration and in heart failure shortens ejection duration. 36 Additional novel characteristics of the AoPW in severe LVSD shown in this study include decreased unaugmented pressure, ejection duration, SDR, percent systolic duration and indices of myocardial oxygen demand, and LV function including unaugmented pressure, PSA, E w , cross product, and SPTI.
Most previous studies performed in patients with mild to moderate heart failure (LVEF 30% to Ͼ40%) showed an increase or no change in arterial stiffness. Only one previous study reported a decrease in arterial stiffness and PWV similar to our findings; this was the study by Tartière et al, 33 performed in patients with severe LVSD and reduced mean arterial pressure. Because the activities of the LV and peripheral arterial system are interactive (ventricular/vascular coupling), the decrease in arterial stiffness and PWV may be the result of a decrease in mean arterial pressure in response to reduced cardiac output and LV afterload. This decreased arterial stiffness and wave reflection-essentially, a decrease in impedance-is partly because of the effect of arterial vasodilating drugs and a decrease in mean arterial pressure which is probably just a marker of severe LV dysfunction. In both the Tartière et al 33 study and this study, a majority of the LVSD patients received either angiotensin converting enzyme inhibiting or angiotension receptor blocking drugs, which decrease peripheral arterial stiffness directly (actively) and central arterial stiffness indirectly (passively).
The measured decreases in systolic unaugmented pressure, E w , and SPTI shown in this study are the result of a decrease in LV contractile function and consequent inability to generate force and pressure to overcome the augmented pressure associated with the severe LVSD resulting in reduced stroke volume and PSA. The decrease in SPTI and cross product indicate a consequent decrease in LV oxygen requirements, and the increase in DPTI/SPTI indicates an increase in myocardial viability ratio. This may serve as a compensatory mechanism in severe LVSD to optimize efficiency of the failing LV.
Morphological changes in the pressure wave contour in systolic heart failure were reported well over a hundred years ago. Flemming suggested in 1881 that the necessary conditions for the presence of 2 distinct upstrokes in the peripheral pulse wave often seen in heart failure included a fast pulse, elastic vessels, feeble tension in the vessels, and a small amount of blood injected with each ventricular systole. 37 A few years later, Lewis 38 described a characteristic dicrotic (twice-beating) pulse, which is typical in patients with LVSD resulting from cardiogenic shock after myocardial infarction, 3, 4, 39 after open heart surgery 40 and in cardiomyopathy. 41, 42 Such morphological changes in pulse contour with LVSD are confined to the peripheral pulse and are seldom seen in the AoPW. 43 Fifty-six percent of the patients in our study displayed a dicrotic wave in the radial pulse ( Figure 2 ).
An explanation for the progression from normal LV systolic function to severe LVSD is available on the basis of the argument proposed by Westerhof and O'Rourke 36 and Nichols and O'Rourke. 4 This explanation has been effectively used to characterize mechanical pumps, with the LV seen to act as a flow source (powerful ejection) in youth when the ventricle is optimally matched to a compliant arterial system and power generation is minimal. Under these circumstances, stroke volume is directly related to PSA and the reflected wave arrives in diastole ( Figure 4A ) and aids in coronary artery perfusion. The age-related increase in elastic artery stiffness (and PWV) causes the reflected wave to arrive earlier to the heart and boost pressure in late systole that places an extra pulsatile workload on the LV causing it to generate more force, which is wasted effort. These changes in arterial properties and wave reflection characteristics cause the LV to change from a flow source to a combined flow and pressure source (ejection limited by pressure achieved) as hypertension develops ( Figure 4B ). As the elastic arteries become stiffer, the LV becomes primarily a pressure source and the myocardial oxygen demand is greater. Sustained elevation and prolongation of late systolic augmentation results in LV hypertrophy, 26, 44, 45 which is associated with progressive degenerative changes in the myocytes such that these weaken and develop less force with each contraction. The weakened, hypertrophied fibers lengthen and the LV dilates, with augmented systolic pressure and stroke output initially being maintained ( Figure 4C ) at greater muscle length and LV volume through the Frank-Starling mechanism. 3, 4 The LVEF in these patients is usually Յ40%. Ultimately, compensation is lost and the LV cannot generate the extra force necessary to completely overcome the late systolic augmented pressure. Augmented pressure, AI a , and in an increase in AI a, wasted effort, cPP (59 mm Hg), SPTI (3206 mm Hg sec/min) and PSA (802 mm Hg sec/min) causing LV hypertrophy which begins the process of systolic heart failure. C, As heart failure proceeds reflected wave amplitude (7 mm Hg), AI a , cPP, ejection duration (269 ms), SPTI (2196 mm Hg sec/min), and PSA (558 mm Hg sec/min) begin to decrease. D, In LVSD, the augmented systolic pressure and wasted effort become almost zero, LV ejection is shortened further (235 ms) which causes a reduction in SPTI (1535 mm Hg sec/min), percent systolic duration (28%) and PSA (361 mm Hg sec/min). systolic (and pulse) pressure are therefore reduced and associated with a decrease in ejection duration, E w , PSA, SPTI, and stroke volume. The LVEF in these patients is usually Ͻ30%. 33 When LV contractility is severely impaired, wave reflection does not boost systolic pressure ( Figure 4C ) because the heart is incapable of responding, so that systole is terminated prematurely, and wave reflection is seen to have had a negative influence on flow rather than a positive influence on pressure 3, 33 and the LV reverts back to a flow source (weak and abbreviated ejection) as heart failure progresses ( Figure 4D) . Again there is a direct positive relation between stroke volume and PSA; therefore, an improvement in hemodynamics will be viewed as an increase in ejection duration, augmented pressure, pulse pressure, and PSA. 9
Limitations
This study has one principal limitation. The radial artery pressure waveforms were calibrated using cuff measured brachial systolic and diastolic pressure. However, this method of calibration may result in an overestimation of the central aortic pressures. 46, 47 Nonetheless, this overestimation should be a systematic error and affect all results proportionately.
Conclusions
PWA of the AoPW may provide more detailed and accurate information into the severity of LV dysfunction compared with the measures of brachial pulsatility. This information may prove vital in the diagnosis and risk stratification of patients with LV dysfunction, especially when severe, and yet may be performed accurately in the outpatient clinic setting. Further standardization of AoPW findings in LVSD patients may allow for the clinical use of arterial PWA to noninvasively characterize reduced LV systolic performance, including severe LVSD and aid in logical therapy.
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